BIOSANTE PHARMACEUTICALS, INC. |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| May. 21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
| May. 20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
Chart calendar BioSante Pharmaceuticals, Inc.
1048e9203d4.StZKFjAC2x2j9wkYpSno__YEJ8NTfZAkXWhUf-A5oBE.FZ1zZwVBk2SWwE984UK4oLBnYJAhG9kJDh8dL81L80c4kDlcck6wRM6GQA~e98daa85fad0b20cfb23f716e77294f1
Upcoming events on BioSante Pharmaceuticals, Inc.
Past events on BioSante Pharmaceuticals, Inc.
| 2024-05-21 09:00 am | Annual General Meeting |
| 2024-05-20 09:00 am | H.C. Wainwright BioConnect Investor Conference |
| 2024-05-14 12:15 pm | Capital One Biotech Disruptors Conference |
| 2024-05-10 08:30 am | Q1 2024 Earnings Call |
| 2024-05-10 06:50 am | Q1 2024 Earnings Release |
| 2024-04-16 | Piper Sandler Spring Biopharma Symposium |
| 2024-03-12 02:20 pm | Leerink Partners Global Biopharma Conference |
| 2024-02-29 08:30 am | Q4 2023 Earnings Call |
| 2024-02-29 06:50 am | Q4 2023 Earnings Release |
| 2024-02-08 10:30 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-28 01:00 pm | Piper Sandler Healthcare Conference |
| 2023-11-15 10:00 am | Jefferies London Healthcare Conference |
| 2023-11-08 08:30 am | Q3 2023 Earnings Call |
| 2023-11-08 06:50 am | Q3 2023 Earnings Release |
| 2023-09-26 11:40 am | Cantor Global Healthcare Conference |
| 2023-09-12 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-09 08:30 am | Q2 2023 Earnings Call |
| 2023-08-09 06:50 am | Q2 2023 Earnings Release |
| 2023-06-09 08:30 am | Jefferies Global Healthcare Conference |
| 2023-05-23 09:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 207 210 -1.85% | 208 205 1.51% | 216 212 2.14% | 316 308 2.89% | 487 480 1.42% | 539 |
|
EBITDA Million USD | Released Forecast Spread | 83,2 85,5 -2.74% | 67,1 68,0 -1.3% | 64,8 64,8 0.06% | 55,9 54,1 3.26% | 134 133 0.87% | 138 |
|
EBIT Million USD | Released Forecast Spread | 16,4 26,4 -38.06% | -16,0 -11,4 -40.49% | -39,8 -17,1 -132.71% | -35,3 -34,0 -3.77% | 47,0 49,5 -5.19% | 52,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,16 13,2 -76.08% | -26,0 -20,9 -24.22% | -56,1 -28,4 -97.39% | -62,7 -61,4 -2.13% | 19,9 21,8 -8.95% | 44,2 |
|
Net income Million USD | Released Forecast Spread | 6,09 12,8 -52.39% | -22,5 -16,9 -33.42% | -42,8 -20,9 -104.75% | -49,5 -47,9 -3.32% | 17,2 19,9 -13.99% | 33,1 |
|
EPS USD | Released Forecast Spread | 0,50 1,06 -52.83% | -1,88 -1,41 -33.33% | -3,40 -0,88 -288.57% | -3,05 -2,94 -3.86% | 0,85 0,92 -7.61% | 1,57 |
| Announcement Date | 27/02/20 | 09/03/21 | 15/03/22 | 09/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 64,5 65,0 -0.86% | 73,9 72,0 2.62% | 83,8 78,4 6.97% | 94,2 86,1 9.4% | 107 83,5 27.92% | 117 99,9 16.71% | 132 112 17.79% | 132 125 5.38% | 137 126 9.05% | 131 | 136 | 141 | 132 | 141 |
|
EBITDA Million USD | Released Forecast Spread | 4,27 7,70 -44.51% | 9,86 9,50 3.8% | 19,6 19,5 0.52% | 23,3 23,2 0.56% | 33,0 16,4 101.3% | 34,1 22,8 49.51% | 36,5 27,5 32.55% | 30,2 28,3 6.59% | 37,6 31,1 21.08% | 30,7 | 34,6 | 37,2 | 31,6 | 36,8 |
|
EBIT Million USD | Released Forecast Spread | -19,2 -9,30 -106.4% | -12,9 -9,10 -41.9% | -5,00 0,40 -1348.75% | 1,82 3,10 -41.29% | 9,90 -1,30 861.15% | 12,4 1,96 531.79% | 17,9 7,41 142.28% | 6,73 7,55 -10.91% | 20,3 9,66 110.33% | 7,72 | 10,9 | 13,6 | 8,63 | 13,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,9 -15,4 -68.16% | -18,8 -15,0 -25.45% | -12,2 -5,20 -135.04% | -5,73 -3,00 -90.93% | 2,17 -9,30 123.28% | 5,25 -5,04 204.21% | 11,5 0,31 3637.34% | 0,95 1,15 -17.69% | 25,3 3,88 552.29% | 3,17 | 6,44 | 9,23 | 4,13 | 9,00 |
|
Net income Million USD | Released Forecast Spread | -20,5 -11,9 -72.56% | -15,3 -11,3 -35.66% | -9,01 -4,30 -109.44% | -4,65 -2,60 -78.85% | 1,03 -7,50 113.77% | 5,84 -3,75 255.56% | 9,53 0,38 2382.81% | 0,75 0,91 -17.74% | 18,2 3,03 500% | 2,54 | 5,15 | 7,38 | 3,30 | 7,20 |
|
EPS USD | Released Forecast Spread | -1,27 -0,67 -89.55% | -0,94 -0,64 -48.03% | -0,55 -0,27 -101.22% | -0,28 -0,19 -47.37% | 0,06 -0,52 111.61% | 0,29 -0,18 265.71% | 0,45 0,04 1025% | 0,04 0,07 -40% | 0,82 0,15 459.08% | 0,18 | 0,34 | 0,46 | 0,15 | 0,34 |
| Announcement Date | 10/05/22 | 08/08/22 | 09/11/22 | 09/03/23 | 08/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | 10/05/24 | - | - | - | - | - |
More events
Past sector events for BioSante Pharmaceuticals, Inc.
| 2024-05-30 08:08 am | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 am | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 am | FDC LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 05:26 am | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:44 am | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 04:10 am | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 2024-05-28 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 2024-05-27 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-27 08:10 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
- Stock Market
- Equities
- ANIP Stock
- Stock
- Calendar BioSante Pharmaceuticals, Inc.
